+
Site Tour

EACTS 2022 Symposium: When can Tendyne TMVR be a relevant substitute for on-pump MVR?

Rudiger Lange’s presentation from a symposium held at EACTS 2022: From established to advanced therapies and technologies that change lives.

Related Videos

AV Valves Summit 2024 | Closing of Day 1

Mechanical Heart Valve Patient Story: Javier

Navitor™: Voice of the Experts Lars Sondergaard

Navitor™: Voice of the Experts Nicolas Dumonteil

TAVI Case-Club – Alternative access

TAVI Summit - PreTAVR CT analysis

Navitor™: Voice of the Experts Mohammed Saad

EuroPCR 2023: Mitral regurgitation

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Transfemoral TAVI

Navitor Vision 35 implantation

CONNEXT


HUB
RELATED RESOURCES

ESC 2021: HF & VHD Guidelines

Tendyne™: 6-Year Outcomes

PCRLV 2022: bRIGHT 30 days

EXPAND Study: Data overview

CONNEXT


LIVE
RELATED EVENTS

AV VALVES 2023: Trending Topics – Complexity

Navigating the Anatomy | Mitral focus

TAVI Summit - TAVR in bicuspid

Echo course mitral TEER – cases

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline